ArticleBMC nephrology2023

Can regulatory T cells improve outcomes of sensitised patients after HLA-Ab incompatible renal transplantation: study protocol for the Phase IIa GAMECHANgER-1 trial.

C Dudreuilh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.